Detection of self-reactive CD8+ T cells with an anergic phenotype in healthy individuals
暂无分享,去创建一个
D. Sugiyama | D. Adeegbe | S. Sakaguchi | J. Wing | I. Katayama | Y. Maeda | H. Nishikawa | M. Hamaguchi | D. Ha | Takuro Saito | M. Nishioka
[1] Peter E. Czabotar,et al. Control of apoptosis by the BCL-2 protein family: implications for physiology and therapy , 2013, Nature Reviews Molecular Cell Biology.
[2] J. Karbach,et al. Anti-CCR4 mAb selectively depletes effector-type FoxP3+CD4+ regulatory T cells, evoking antitumor immune responses in humans , 2013, Proceedings of the National Academy of Sciences.
[3] Hiromasa Morikawa,et al. Construction of self-recognizing regulatory T cells from conventional T cells by controlling CTLA-4 and IL-2 expression , 2013, Proceedings of the National Academy of Sciences.
[4] E John Wherry,et al. Network analysis reveals centrally connected genes and pathways involved in CD8+ T cell exhaustion versus memory. , 2012, Immunity.
[5] Burton E. Barnett,et al. Progenitor and Terminal Subsets of CD8+ T Cells Cooperate to Contain Chronic Viral Infection , 2012, Science.
[6] Yan Zheng,et al. Transcriptional regulator early growth response gene 2 (Egr2) is required for T cell anergy in vitro and in vivo , 2012, The Journal of experimental medicine.
[7] Sheng Xiao,et al. Bat3 promotes T cell responses and autoimmunity by repressing Tim-3–mediated cell death and exhaustion , 2012, Nature Medicine.
[8] C. Hsieh,et al. Selection of regulatory T cells in the thymus , 2012, Nature Reviews Immunology.
[9] E. Wherry. T cell exhaustion , 2011, Nature Immunology.
[10] G. Anderson,et al. Trans-Endocytosis of CD80 and CD86: A Molecular Basis for the Cell-Extrinsic Function of CTLA-4 , 2011, Science.
[11] R. Schwartz,et al. Induction of T cell anergy: integration of environmental cues and infectious tolerance. , 2010, Current opinion in immunology.
[12] A. Wells. New Insights into the Molecular Basis of T Cell Anergy: Anergy Factors, Avoidance Sensors, and Epigenetic Imprinting , 2009, The Journal of Immunology.
[13] E. Shevach. Mechanisms of foxp3+ T regulatory cell-mediated suppression. , 2009, Immunity.
[14] T. Nomura,et al. CTLA-4 Control over Foxp3+ Regulatory T Cell Function , 2008, Science.
[15] M. Bevan,et al. Effector and memory CTL differentiation. , 2007, Annual review of immunology.
[16] J. Bluestone,et al. CTLA4Ig: bridging the basic immunology with clinical application. , 2006, Immunity.
[17] R. Ahmed,et al. Restoring function in exhausted CD8 T cells during chronic viral infection , 2006, Nature.
[18] S. Sakaguchi. Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self , 2005, Nature Immunology.
[19] D. Mueller. E3 ubiquitin ligases as T cell anergy factors , 2004, Nature Immunology.
[20] J. Penninger,et al. Essential role of the E3 ubiquitin ligase Cbl-b in T cell anergy induction. , 2004, Immunity.
[21] A. Rao,et al. T-cell anergy. , 2004, Current opinion in immunology.
[22] C. Fathman,et al. GRAIL: an E3 ubiquitin ligase that inhibits cytokine gene transcription is expressed in anergic CD4+ T cells. , 2003, Immunity.
[23] R. Schwartz. T cell anergy. , 2003, Annual review of immunology.
[24] G. Freeman,et al. The B7–CD28 superfamily , 2002, Nature Reviews Immunology.
[25] H. Rammensee,et al. HLA-A2 restricted, melanocyte-specific CD8(+) T lymphocytes detected in vitiligo patients are related to disease activity and are predominantly directed against MelanA/MART1. , 2001, The Journal of investigative dermatology.
[26] F. Sallusto,et al. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions , 1999, Nature.
[27] D. Speiser,et al. High Frequencies of Naive Melan-a/Mart-1–Specific Cd8+ T Cells in a Large Proportion of Human Histocompatibility Leukocyte Antigen (Hla)-A2 Individuals , 1999, The Journal of experimental medicine.
[28] F. Otsuka,et al. Thymus and autoimmunity: production of CD25+CD4+ naturally anergic and suppressive T cells as a key function of the thymus in maintaining immunologic self-tolerance. , 1999, Journal of immunology.
[29] G. Ogg,et al. High Frequency of Skin-homing Melanocyte-specific Cytotoxic T Lymphocytes in Autoimmune Vitiligo , 1998, The Journal of experimental medicine.
[30] P. Romero,et al. Cytolytic T lymphocyte recognition of the immunodominant HLA-A*0201-restricted Melan-A/MART-1 antigenic peptide in melanoma. , 1997, Journal of immunology.
[31] X. Jin,et al. The human cytotoxic T-lymphocyte (CTL) response to cytomegalovirus is dominated by structural protein pp65: frequency, specificity, and T-cell receptor usage of pp65-specific CTL , 1996, Journal of virology.
[32] K. Sakaguchi,et al. Identification of a human melanoma antigen recognized by tumor-infiltrating lymphocytes associated with in vivo tumor rejection. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[33] J. Renauld,et al. A new gene coding for a differentiation antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas , 1994, The Journal of experimental medicine.
[34] R. Schwartz,et al. Antigen presentation by chemically modified splenocytes induces antigen- specific T cell unresponsiveness in vitro and in vivo , 1987, The Journal of experimental medicine.
[35] D. Mueller. Mechanisms maintaining peripheral tolerance , 2010, Nature Immunology.
[36] Antonio Polley,et al. Coregulation of CD8+ T cell exhaustion by multiple inhibitory receptors during chronic viral infection , 2009, Nature Immunology.